(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 15.50%-1.96M | -36.91%-4.04M | -21.47%-2.48M | -27.27%-10.56M | -97.87%-3.25M | 4.01%-2.32M | -69.13%-2.95M | 18.07%-2.05M | 26.87%-8.3M | 27.36%-1.64M |
Net income from continuing operations | 21.22%-2.65M | -22.03%-3.23M | 10.75%-1.82M | -222.25%-24.94M | -539.94%-16.89M | -136.81%-3.37M | 5.53%-2.65M | -132.27%-2.04M | 61.11%-7.74M | -17.18%-2.64M |
Operating gains losses | 50.74%205K | 210.31%107K | 3,350.00%138K | 99.11%-13K | -7.69%-56K | 277.78%136K | -3,133.33%-97K | 100.28%4K | -1,029.46%-1.46M | 11.86%-52K |
Depreciation and amortization | 0.00%3K | 0.00%3K | 0.00%3K | -56.00%11K | -60.00%2K | -57.14%3K | -50.00%3K | -57.14%3K | -19.35%25K | -28.57%5K |
Asset impairment expenditure | --6K | --17K | --19K | --486K | --486K | --0 | --0 | --0 | --0 | ---- |
Remuneration paid in stock | --0 | ---96K | -189.12%-691K | -98.85%9K | -110.88%-62K | 1,133.33%310K | --0 | -446.38%-239K | 92.18%786K | 740.45%570K |
Other non cashItems | 19,800.00%197K | 9,250.00%183K | 4,600.00%45K | 16.67%-5K | 50.00%-1K | 0.00%-1K | 0.00%-2K | 0.00%-1K | -100.11%-6K | 60.00%-2K |
Change In working capital | -53.11%279K | -395.63%-1.02M | -180.44%-181K | 15,159.34%13.89M | 2,682.39%13.27M | 158.91%595K | -123.41%-206K | 187.89%225K | -96.01%91K | 238.30%477K |
-Change in receivables | 24.14%-22K | 400.00%21K | -169.23%-45K | 1,116.67%61K | -91.35%32K | 90.27%-29K | 50.00%-7K | 201.56%65K | -105.22%-6K | 1,188.24%370K |
-Change in prepaid assets | 392.97%631K | -707.92%-1.46M | 20.62%-281K | 74.70%145K | 33.67%131K | -60.00%128K | 217.65%240K | -170.23%-354K | 186.46%83K | 380.00%98K |
-Change in payables and accrued expense | -166.33%-329K | 194.99%417K | -71.98%144K | 792.86%125K | -5,055.56%-446K | 148.06%496K | -139.98%-439K | 942.62%514K | -99.38%14K | -95.54%9K |
-Change in other current liabilities | ---- | ---- | ---- | ---206K | ---- | ---- | ---- | ---- | --0 | --0 |
-Change in other working capital | ---- | --0 | --1K | --13.76M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 15.55%-1.96M | -36.91%-4.04M | -21.52%-2.49M | -27.27%-10.56M | -97.87%-3.25M | 4.01%-2.32M | -69.13%-2.95M | 18.07%-2.05M | 26.87%-8.3M | 27.36%-1.64M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 500.00%4K | 0.00%-1K | -123.33%-7K | -99.74%9K | -106.46%-19K | -100.13%-1K | -100.12%-1K | -98.07%30K | 308.65%3.49M | -64.10%294K |
Net PPE purchase and sale | 500.00%4K | 50.00%-1K | ---7K | -101.67%-24K | -2,000.00%-21K | ---1K | -100.57%-2K | --0 | --1.44M | ---1K |
Net other investing changes | ---- | ---- | ---- | -98.39%33K | -99.32%2K | --0 | -99.80%1K | -93.46%30K | 140.35%2.06M | -63.98%295K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 500.00%4K | 0.00%-1K | -123.33%-7K | -99.74%9K | -106.46%-19K | -100.13%-1K | -100.12%-1K | -98.07%30K | 308.65%3.49M | -64.10%294K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0.00%-1K | -32.00%4.35M | 54K | 36.91%9.62M | 3.23M | -150.00%-1K | 6.39M | 0 | -2.52%7.03M | 0 |
Net common stock issuance | --2K | ---- | ---- | -9.48%6.44M | --0 | --0 | ---- | ---- | -4.56%7.12M | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | --54K | --3.23M | --3.23M | --0 | --0 | --0 | --0 | ---- |
Net other financing activities | -200.00%-3K | ---- | ---- | 40.00%-54K | --0 | -200.00%-1K | ---- | ---- | 62.03%-90K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 0.00%-1K | -32.00%4.35M | --54K | 36.91%9.62M | --3.23M | -150.00%-1K | --6.39M | --0 | -2.52%7.03M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -64.88%2.48M | -39.78%2.17M | -17.97%4.61M | 70.80%5.62M | -33.54%4.64M | -16.97%7.05M | 54.19%3.61M | 70.80%5.62M | -49.23%3.29M | 47.27%6.99M |
Current changes in cash | 15.75%-1.96M | -91.05%308K | -20.99%-2.44M | -141.88%-931K | 97.55%-33K | -42.75%-2.32M | -43.99%3.44M | -113.23%-2.02M | 167.71%2.22M | 6.46%-1.35M |
Effect of exchange rate changes | 149.37%39K | -500.00%-4K | -100.00%-2K | -173.83%-79K | --0 | -161.24%-79K | -83.33%1K | 87.50%-1K | 16.30%107K | -42.86%-20K |
End cash Position | -88.03%556K | -64.88%2.48M | -39.78%2.17M | -17.97%4.61M | -17.97%4.61M | -33.54%4.64M | -16.97%7.05M | 54.19%3.61M | 70.80%5.62M | 70.80%5.62M |
Free cash from | 15.76%-1.96M | -36.85%-4.04M | -21.86%-2.49M | -27.50%-10.59M | -99.03%-3.27M | 3.97%-2.32M | -69.25%-2.95M | 18.17%-2.05M | 26.83%-8.3M | 27.31%-1.64M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data